{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:46:10Z","timestamp":1764510370719},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T00:00:00Z","timestamp":1264809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1752-1947-4-32","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T14:14:39Z","timestamp":1264860879000},"source":"Crossref","is-referenced-by-count":4,"title":["Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Robin H","family":"Johns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Cwynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne R","family":"Cleverley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banwari","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,30]]},"reference":[{"issue":"12","key":"994_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","volume":"147","author":"M Bower","year":"2007","unstructured":"Bower M, Powles T, Williams S: Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med. 2007, 147 (12): 836-9.","journal-title":"Ann Intern Med"},{"issue":"8","key":"994_CR2","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1182\/blood-2003-03-0951","volume":"102","author":"AG Marcelin","year":"2003","unstructured":"Marcelin AG, Aaron L, Mateus C: Rituximab therapy for HIV-associated Castleman disease. Blood. 2003, 102 (8): 2786-8. 10.1182\/blood-2003-03-0951.","journal-title":"Blood"},{"issue":"3","key":"994_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00277-005-0038-4","volume":"85","author":"A Casquero","year":"2006","unstructured":"Casquero A, Barroso A, Fernandez Guerrero ML, Gorgolas M: Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol. 2006, 85 (3): 185-7. 10.1007\/s00277-005-0038-4.","journal-title":"Ann Hematol"},{"issue":"2","key":"994_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1378\/chest.113.2.421","volume":"113","author":"E Casalino","year":"1998","unstructured":"Casalino E, Mendoza-Sassi G, Wolff M: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest. 1998, 113 (2): 421-9. 10.1378\/chest.113.2.421.","journal-title":"Chest"},{"issue":"6","key":"994_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1600-0609.2005.00418.x","volume":"74","author":"AD Cornet","year":"2005","unstructured":"Cornet AD, Issa AI, Loosdrecht van de AA, Ossenkoppele GJ, Strack van Schijndel RJ, Groeneveld AB: Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol. 2005, 74 (6): 511-6. 10.1111\/j.1600-0609.2005.00418.x.","journal-title":"Eur J Haematol"},{"issue":"1","key":"994_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00134-005-2836-5","volume":"32","author":"DD Benoit","year":"2006","unstructured":"Benoit DD, Depuydt PO, Vandewoude KH: Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med. 2006, 32 (1): 93-9. 10.1007\/s00134-005-2836-5.","journal-title":"Intensive Care Med"},{"issue":"9","key":"994_CR7","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/leu.2008.54","volume":"22","author":"SM Schmidt","year":"2008","unstructured":"Schmidt SM, Raible A, Kortum F: Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure. Leukemia. 2008, 22 (9): 1782-5. 10.1038\/leu.2008.54.","journal-title":"Leukemia"},{"issue":"3","key":"994_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QAD.0b013e32831c54e5","volume":"23","author":"WF Bierman","year":"2009","unstructured":"Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA: HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review. AIDS. 2009, 23 (3): 279-91. 10.1097\/QAD.0b013e32831c54e5.","journal-title":"AIDS"},{"issue":"4","key":"994_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00134-004-2210-z","volume":"30","author":"RP Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004, 30 (4): 536-55. 10.1007\/s00134-004-2210-z.","journal-title":"Intensive Care Med"},{"issue":"1","key":"994_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2006.05.002","volume":"22","author":"CS Bouman","year":"2007","unstructured":"Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB: Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care. 2007, 22 (1): 1-12. 10.1016\/j.jcrc.2006.05.002.","journal-title":"J Crit Care"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-4-32\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:40:33Z","timestamp":1548117633000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-4-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,30]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-4-32","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,30]]},"article-number":"32"}}